Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03133156 · ClinicalTrials.gov registry record · NA

Exercise Regulation of Human Adipose Tissue

A NA study, sponsored by Joslin Diabetes Center.

Completed
Registry status
NA
Development phase
93
Enrollment target

NCT03133156: Completed NA study, sponsored by Joslin Diabetes Center.

NCT03133156 is a NA study that has completed, run by Joslin Diabetes Center. The registered enrollment target is 93 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03133156, a NA study, has completed, sponsored by Joslin Diabetes Center.

COMPLETED
Registry status
NA
Development phase
93 participants
Enrollment target

Study Summary

The purpose of this study is to determine whether exercise training leads to changes in the white adipose tissue that are beneficial to the body's regulation of sugar and body weight.

Primary Outcome

Body fat percentage measured before and after exercise training with a bioelectrical impedance scale.

Interventions

  • OTHER Exercise Intervention

Trial Details

FieldValue
Enrollment Target 93 participants
Start Date 2017-06-15
Est. Completion 2024-06-24
Phase NA
Joslin Diabetes Center

73 total trials

What the finished NCT03133156 record still lists

NCT03133156 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 93 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).

The record links to 0 conditions, and to 1 intervention - of which Exercise Intervention is the first listed.

NCT03133156 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03133156 about?

NCT03133156 is a clinical study titled "Exercise Regulation of Human Adipose Tissue". The purpose of this study is to determine whether exercise training leads to changes in the white adipose tissue that are beneficial to the body's regulation of sugar and body weight.

What is the current status of trial NCT03133156?

This trial is currently completed. It is a NA study. The enrollment target is 93 participants. The study started on 2017-06-15. Estimated completion is 2024-06-24.

What interventions are being tested in trial NCT03133156?

The interventions under investigation include: Exercise Intervention (OTHER).

Who is sponsoring clinical trial NCT03133156?

This trial is sponsored by Joslin Diabetes Center, which has 73 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03133156's enrollment target sits among peer trials

93 937th of 2000 higher than 1,064 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02203526 · 93 participants · Phase 1

    Phase 1 Study of Ibrutinib and Immuno-Chemotherapy Using Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib,Rituximab (TEDDI-R) in Primary CNS Lymphoma

  • NCT03089554 · 93 participants · Phase 2

    Evaluating Genomic Testing in Human Cancer & Outcomes of Targeted Therapies

  • NCT05000021 · 93 participants · NA

    Reducing Diabetes Distress Using Cognitive Behavioral Therapy in Young Adults With Type 1 Diabetes

  • NCT05489887 · 93 participants · Phase 2

    Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03133156, the US trial registry maintained by the National Library of Medicine. NCT03133156 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.